Dr Sara Saad

BMT and Hematology Oncology Pharmacotherapy Specialist

Cleveland Clinic Abu Dhabi

Abu Dhabi, UAE

At the 1st Emirates Hematology Forum, 31 October 2026

Panelist · 10:05–10:35
Panel Discussion: Optimal Duration of Maintenance Therapy in Frontline Multiple Myeloma: When, If Ever, Should We Stop? · Sequencing of Therapies in Second Line: CAR-T then BiTEs or BiTEs then CAR-T
Session: Rewriting the Myeloma Playbook

See the full Forum programme

To correct or remove this profile, write to secretariat@eora.ae.